This inventor holds 1 USPTO granted patent. Top assignee: Madaus Gmbh & Co.. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovative Contributions of Peter Gmeiner
Introduction
Peter Gmeiner is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals through his innovative research and development. His work focuses on the synthesis of new compounds that exhibit useful pharmaceutical properties.
Latest Patents
Peter Gmeiner holds a patent for "Derivatives of 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonines." This patent includes new compounds of the formula that are prepared from ketones via a lactone intermediate. The various R substitutes in the formula are generally hydrogen or alkyl, with specific variations that include halogen or alkoxy. The starting ketones also possess pharmaceutical properties, making the lactone intermediates valuable new compounds. He has 1 patent to his name.
Career Highlights
Peter Gmeiner is associated with Madaus GmbH & Co., where he continues to contribute to pharmaceutical innovations. His work has been instrumental in advancing the understanding and application of benzoxazonine compounds in medicine.
Collaborations
Throughout his career, Peter has collaborated with esteemed colleagues such as Friedrich Eiden and Jurgen Schunemann. These partnerships have enhanced the scope and impact of his research.
Conclusion
Peter Gmeiner's innovative work in the pharmaceutical field exemplifies the importance of research and development in creating new therapeutic compounds. His contributions continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile